Global Gene Therapies

The Future of Medicine Shouldn't Depend on Where You're Born.

Cell and gene therapies are redefining what's possible in medicine. They can cure diseases once thought incurable. Yet today, fewer than 0.1% of the people who could benefit ever receive them. GGTI brings together scientists, clinicians, patients, regulators, governments, industry and investors to ensure these breakthroughs reach everyone.

Join the Network

Problem

Why GGTI Exists

We believe access should be designed into innovation—not added later. GGTI’s mission is to make transformative genetic and cellular medicines available to patients anywhere in the world who want and need them through early and continuous engagement of all key stakeholders from the very beginning.

Our Approach

Four pillars:
• Weekly Global Collaboration
• Capacity Building
• Policy & Regulation
• Technology Development

Focus Areas

Community Engagement
Capacity Building
Regulatory Development
Technology Innovation

Our Story

Dr. Cissy Kityo-Mutuluuza had heard

‘maybe in another 10–15 years’

too many times. After failing to meaningfully engage gene therapy developers for access to treatment for her patients with sickle cell and HIV in Uganda, she discovered a TEDx talk about how to make this work. All it took was one phone call to find Dr. Jennifer Adair and get connected to a host of others anxious about access to transformative treatments. This grassroots group founded GGTI to ensure equitable access becomes part of innovation from day one.

Our Reach.

Incredible Science. Unequal Access.

Although dozens of cell and gene therapies are in development or already approved, the overwhelming majority of patients remain excluded because of cost, infrastructure and geography. Most low- and middle-income countries have been left out of the clinical development pipeline.

0 M

people living with HIV worldwide

0 %

of people living with HIV and SCD live in Africa

0 k+

children born with sickle cell disease annually

0 %

or fewer eligible patients have access to gene therapy

The number of cell and gene therapy trials for sickle cell or HIV which have taken place around the world

The number of cell and gene therapy trials for sickle cell or HIV which have taken place in Africa

Our Causes.

Popular Achievements

WHO Selects Uganda as Gene Therapy Pilot Nation

I would say getting Uganda named as a test case country for implementation of regulatory infrastructure for gene and cell therapy by the international World Health Organization.

Featured Speaker at the 5th Global Sickle Cell Conference (Nigeria)

Then presenting you to the 5th Global Sickle cell Conference in Nigeria last year.

JABASA Community Artwork Featured on Science Translational Medicine Cover

Also Moses supercharger’s JABASA Center and community events – the painting from there which was featured on the cover of Science Translational Medicine.

From Our Community.

Success Stories

Meet One Monthly Donor Who Is Fueling A Mission In India

Incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt...

Meet Local Leaders Fighting For Equality